SEC Seal
SEC Banner
Search the Next-Generation EDGAR System
Filing Detail
Form 4 - Statement of changes in beneficial ownership of securities:
SEC Accession No. 0001178913-22-002173
Filing Date
2022-05-25
Accepted
2022-05-25 16:03:50
Documents
1
Period of Report
2022-05-24

Document Format Files

Seq Description Document Type Size
1 zk2227908.html 4  
1 zk2227908.xml 4 10151
  Complete submission text file 0001178913-22-002173.txt   11613
Mailing Address KIRYAT ATIDIM, BUILDING 7 TEL AVIV L3 6158002
Business Address KIRYAT ATIDIM, BUILDING 7 TEL AVIV L3 6158002 972-77-331-0156
Chemomab Therapeutics Ltd. (Issuer) CIK: 0001534248 (see all company filings)

IRS No.: 813676773 | Fiscal Year End: 1231
SIC: 2834 Pharmaceutical Preparations

Mailing Address 5 ATZMON ST. HASHMONAIM L3 7312700
Business Address
Maryles Joel Michael (Reporting) CIK: 0001850990 (see all company filings)

Type: 4 | Act: 34 | File No.: 001-38807 | Film No.: 22962865